 Home > Active Ingredient News > Antitumor Therapy > UK real-world research proves that HPV vaccine can reduce cervical cancer by 87%

UK real-world research proves that HPV vaccine can reduce cervical cancer by 87%

 Last Update: 2021-12-04
 Source: Internet
 Author: User

Tags

anti cancer tea

anticancer research

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

HPV is the most common sexually transmitted infection (STI)

Infect

Recently, researchers from King's College London revealed that by mid-2019, the HPV vaccination program has prevented approximately 450 cases of cervical cancer and 17,200 cases of precancerous lesions

Prevent Lancet Diagnosis

In England, the vaccine program started in 2008 when a bivalent vaccine-Cervarix-was used to protect women from the two most common types of HPV

In the study, the three cohorts of the vaccinated population included women who were vaccinated with Cervarix between the ages of 12-13, 14-16, and 16-18

They found that among women who were vaccinated between the ages of 14-16, the incidence of cervical cancer was reduced by 62%, and among women who were vaccinated between the ages of 16-18, the incidence of cervical cancer was reduced by 34%

Screening for COVID-19

Original source:

https:// href="https://" target="_blank" rel="noopener">https:// https://

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gefitinib

CAS No.: 184475-35-2

Pharmacy Grade

$1/MT FOB

High quality Sunitinib CAS NO 557795-19-4 Orange solid powder 99% API for antitumor

CAS No.: 557795-19-4

Pharmacy Grade

$4.1-4.2/G FOB

Epirubicin

CAS No.: 56420-45-2

$1/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.